HomeCompareSHLM vs MRK

SHLM vs MRK: Dividend Comparison 2026

SHLM yields 4.55% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SHLM wins by $630.5K in total portfolio value
10 years
SHLM
SHLM
● Live price
4.55%
Share price
$44.00
Annual div
$2.00
5Y div CAGR
51.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$687.2K
Annual income
$408,119.20
Full SHLM calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SHLM vs MRK

📍 SHLM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSHLMMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SHLM + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SHLM pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SHLM
Annual income on $10K today (after 15% tax)
$386.36/yr
After 10yr DRIP, annual income (after tax)
$346,901.32/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, SHLM beats the other by $338,572.91/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SHLM + MRK for your $10,000?

SHLM: 50%MRK: 50%
100% MRK50/50100% SHLM
Portfolio after 10yr
$372.0K
Annual income
$208,958.67/yr
Blended yield
56.17%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SHLM
No analyst data
Altman Z
12.1
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SHLM buys
0
MRK buys
0
No recent congressional trades found for SHLM or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSHLMMRK
Forward yield4.55%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR51.4%32.7%
Portfolio after 10y$687.2K$56.8K
Annual income after 10y$408,119.20$9,798.13
Total dividends collected$636.4K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SHLM vs MRK ($10,000, DRIP)

YearSHLM PortfolioSHLM Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,388$688.18$11,206$366.19+$182.00SHLM
2$13,294$1,108.92$12,650$502.35+$644.00SHLM
3$16,057$1,831.69$14,407$694.19+$1.6KSHLM
4$20,311$3,130.27$16,585$967.82+$3.7KSHLM
5$27,335$5,602.71$19,342$1,363.89+$8.0KSHLM
6$39,918$10,669.33$22,913$1,947.19+$17.0KSHLM
7$64,758$22,045.76$27,662$2,823.89+$37.1KSHLM
8$119,896$50,604.82$34,159$4,173.35+$85.7KSHLM
9$260,858$132,569.79$43,337$6,308.80+$217.5KSHLM
10$687,238$408,119.20$56,776$9,798.13+$630.5KSHLM

SHLM vs MRK: Complete Analysis 2026

SHLMStock

A. Schulman, Inc. manufactures and supplies plastic compounds and resins. It offers custom performance colors, including standard and customized colors, organic and inorganic pigments, high chroma colors in translucent or opaque formats, and special effects. The company also provides engineered composites, such as bulk molding compounds, sheet molding compounds, and thick molding compounds, as well as engineered structural composite solutions for original equipment manufacturers and custom molders. In addition, it offers concentrates to enhance the performance, appearance, and processing of plastics for intended applications; additive solutions; and application solutions that minimize the use of plastics, or incorporate the use of recycled plastics or renewable-based polymers, as well as provides films for agriculture, packaging, and personal care and hygiene applications. Further, the company offers polymer solutions, which provide structural integrity; multi-component blends that include polyolefins, nylons, polyesters and elastomers, and others; and formulating know-how with fiber reinforcements, such as glass and carbon, nano-reinforcements, flame retardants, impact modifiers, and UV stabilization. Additionally, it offers size reduction services; specialty powders for rotational molding, oil and gas additives, and sports and leisure products; jet milling services used for products requiring fine particle size; and cryogenic milling services. The company also buys, repackages, and resells polymers for processing types, such as injection molding, blow molding, thermoforming, and film and sheet extruding. It serves packaging, mobility, building and construction, electronics and electrical, agriculture, personal care and hygiene, custom services, sports, home, and leisure markets worldwide. The company was founded in 1928 and is headquartered in Fairlawn, Ohio. As of August 21, 2018, A. Schulman, Inc. operates as a subsidiary of LyondellBasell Industries N.V.

Full SHLM Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SHLM vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SHLM vs SCHDSHLM vs JEPISHLM vs OSHLM vs KOSHLM vs MAINSHLM vs JNJSHLM vs ABBVSHLM vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.